GLP-1s

A fruitist snack cup with jumbo-sized blueberries is depicted on a table.
C-Suite

Ray Dalio is backing a $1 billion blueberry unicorn that sells berries nearly the size of golf balls

By
November 4, 2025
Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro
Health

Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro

By Matty Merritt and Morning Brew
October 31, 2025
The ‘quiet alarm bell’ on U.S. health costs: Employers are backed into a corner, and workers are paying the price
Economy

The ‘quiet alarm bell’ on U.S. health costs: Employers are backed into a corner, and workers are paying the price

By
October 22, 2025
Ozempic
Commentary

Trump wants Medicare to pay for your Ozempic treatment. Taxpayers may foot the bill for billions in fraud

By Ari Yampolsky and Max Voldman
August 12, 2025
Exclusive: The founders of SoulCycle built a startup for relationships, then pivoted to GLP-1 support groups. Now its assets are being acquired by WeightWatchers
Newsletters

Exclusive: The founders of SoulCycle built a startup for relationships, then pivoted to GLP-1 support groups. Now its assets are being acquired by WeightWatchers

By
August 7, 2025
OpenAI CEO Sam Altman testifies during a Senate Commerce, Science and Transportation Committee hearing on May 8, 2025. (Photo: Tom Williams/CQ-Roll Call/Getty Images)
Newsletters

Behold, an AI model from OpenAI that’s…open

By
August 6, 2025
Weight-loss drugs should be first step to prevent heart disease, top cardiology group says
Health

Weight-loss drugs should be first step to prevent heart disease, top cardiology group says

By Michelle Amponsah and Bloomberg
June 20, 2025
Closeup of woman's torso in orange sweater holding injectable weight-loss drug.
Lifestyle

Agency warns that weight-loss drugs can decrease effectiveness of birth control pills

By
June 5, 2025
A group of young women sit around a table at a restaurant.
Health

The Ozempic boom could be bad news for restaurants as more than half of GLP-1 users report cutting back on dining out, report finds

By
June 4, 2025
Interest in GLP-1 medications like Ozempic will continue to grow given the multiple health conditions they can improve.
Commentary

The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up

By
March 4, 2025
Close up of a man's face
Health

50-year-old security guard lost 70 pounds on Wegovy—then gained two pants sizes when he lost insurance coverage

By Tom Murphy and The Associated Press
February 24, 2025
Semaglutide medications Wegovy and Ozempic are pictured
Health

Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers

By Bloomberg, Madison Muller, Ike Swetlitz and Naomi Kresge
February 21, 2025
A woman injects herself with medication.
Health

Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’

By
February 11, 2025
Close-up of cast metal sign for the pharmaceutical company Merck
Health

Merck touts 20 new ‘blockbuster’ drugs in development with $50 billion potential

By
February 4, 2025
Novo Nordisk advertising logo on facade building, Danish pharmaceutical healthcare giant Novo Nordisk AS, production innovative drugs, obesity treatment Ozempic, Mainz, Germany June 15, 2024
Health

Investors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results

By
February 4, 2025

Most Popular